1-5 of 5
Jeffrey Skinner, MHA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Molecular Response at Specific Timepoints in Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Second Generation Tyrosine Kinase Inhibitors

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Ghayas C. Issa, MD, Guillermo Garcia-Manero, MD, Tapan M. Kadia, MD, William G. Wierda, MD PhD, Musa Yilmaz, MD, Courtney D. DiNardo, MD MSCE, Jeffrey Skinner, MHA, Rita Khouri, Naveen Pemmaraju, MD, Patrice Nasnas, MD, Sara E Dellasala, BS, Sherry A. Pierce, BSN, BA, Jorge E. Cortes, MD, Elias Jabbour, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–44.
https://doi.org/10.1182/blood-2020-143023
Published: 2020
Journal Articles

The Comparison of Frontline Lower-Dose Dasatinib 50 Mg/Day to Standard-Dose Dasatinib 100 Mg/Day in Newly Diagnosed Chronic Myeloid Leukemia: A Propensity Score Analysis

Koji Sasaki, MD, Elias Jabbour, MD, Kiran Naqvi, MD MPH, Jeffrey Skinner, MHA, Kristin Anderson, Sara E Dellasala, BS, Musa Yilmaz, MD, Alessandra Ferrajoli, MD, Prithviraj Bose, MD, Philip A. Thompson, MB, MS, Yesid Alvarado, MD, Nitin Jain, MD, Guillermo Garcia-Manero, MD, Koichi Takahashi, MD PhD, Jan A. Burger, MD PhD, Gautam Borthakur, MD, Naveen Pemmaraju, MD, Rita Khouri, Shilpa Paul, PharmD, Sherry A. Pierce, BSN, BA, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–5.
https://doi.org/10.1182/blood-2020-140003
Published: 2020
Journal Articles

Outcomes of Patients with Chronic Myeloid Leukemia Treated with Third-Line Tyrosine Kinase Inhibitors

Koji Sasaki, MD, Elias Jabbour, MD, Ghayas C. Issa, MD, Guillermo Garcia-Manero, MD, Tapan M. Kadia, MD, William G. Wierda, MD PhD, Musa Yilmaz, MD, Courtney D. DiNardo, MD MSCE, Jeffrey Skinner, MHA, Maria Khouri, Naveen Pemmaraju, MD, Patrice Nasnas, MD, Sherry A. Pierce, BSN, BA, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-142954
Published: 2020
Journal Articles

The Impact of Treatment Recommendation By Leukemia Artificial Intelligence Program (LEAP) on Survival in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Elias Jabbour, MD, Farhad Ravandi, MD, Marina Y Konopleva, MD PhD, Gautam M. Borthakur, MD, William G. Wierda, MD PhD, Naval G. Daver, MD, Koichi Takahashi, MD, Kiran Naqvi, MDMPH, Courtney D. DiNardo, MDMSc, Guillermo Montalban Bravo, MD, Rashmi Kanagal-Shamanna, MD, Naveen Pemmaraju, MD, Ghayas C. Issa, MD, Preetesh Jain, MBBS,MDDM,PhD, Jeffrey Skinner, MHA, Mary B. Rios, RN, Sherry A. Pierce, BSN, BA, Kelly Soltysiak, PhD, Junya Sato, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1642.
https://doi.org/10.1182/blood-2019-130148
Published: 2019
Journal Articles

Evaluating the Role of Lower Dose Dasatinib in Newly Diagnosed Early Chronic Phase-Chronic Myeloid Leukemia (CML-CP)

Kiran Naqvi, MDMPH, Jorge E. Cortes, MD, Jeffrey Skinner, MHA, Elias J. Jabbour, MD, Naveen Pemmaraju, MD, Prithviraj Bose, MD, Philip A Thompson, MBBS, Gautam Borthakur, MD, Zeev Estrov, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1611.
https://doi.org/10.1182/blood.V130.Suppl_1.1611.1611
Published: 2017